Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Janssen’s Invokana secures FDA priority review status

pharmaceutical-technologyMay 24, 2019

Tag: Janssen , INVOKANA , FDA

PharmaSources Customer Service